Antibody-drug conjugate drug development: where are the challenges?

被引：0
|
作者：
Wright, Laura [1 ]
Baughman, Sharon [2 ]
Wake, Ashleigh [3 ]
机构：
[1] Intertek Pharmaceut Serv, San Diego, CA 92121 USA
[2] ProPharma Serv LLC, Ventura, CA 93001 USA
[3] Intertek Pharmaceut Serv, Manchester M9 8ZS, Lancs, England
来源：
BIOANALYSIS | 2013年 / 5卷 / 12期
关键词：
antibody-drug conjugate; biopharmaceuticals; drug-to-antibody ratio; PK; STRATEGIES;
D O I：
10.4155/BIO.13.104
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1467 / 1469
页数：3
相关论文
共 50 条
  • [1] Stepping forward in antibody-drug conjugate development
    Jin, Yiming
    Schladetsch, Megan A.
    Huang, Xueting
    Balunas, Marcy J.
    Wiemer, Andrew J.
    PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [2] Hot topics in antibody-drug conjugate development
    Thudium, Karen
    Bilic, Sanela
    BIOANALYSIS, 2013, 5 (24) : 2989 - 2993
  • [3] Antibody-Drug Conjugate Targets
    Teicher, B. A.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (08) : 982 - 1004
  • [4] An Immunosuppressive Antibody-Drug Conjugate
    Wang, Rongsheng E.
    Liu, Tao
    Wang, Ying
    Cao, Yu
    Du, Jintang
    Luo, Xiaozhou
    Deshmukh, Vishal
    Kim, Chan Hyuk
    Lawson, Brian R.
    Tremblay, Matthew S.
    Young, Travis S.
    Kazane, Stephanie A.
    Wang, Feng
    Schultz, Peter G.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (09) : 3229 - 3232
  • [5] The antibody-drug conjugate landscape
    Flynn, Patrick
    Suryaprakash, Smruthi
    Grossman, Dan
    Panier, Val
    Wu, John
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 577 - 578
  • [6] Development of an antibody-drug conjugate with broad anticancer activity
    Lin, Siang-Yo
    Szekely, Zoltan
    Lin, Chen-Yong
    Bertino, Joseph R.
    Rather, Gulam Mohmad
    CANCER RESEARCH, 2017, 77
  • [7] Challenges in antibody-drug conjugate discovery: a bioconjugation and analytical perspective
    Rao, Chetana
    Rangan, Vangipuram S.
    Deshpande, Shrikant
    BIOANALYSIS, 2015, 7 (13) : 1561 - 1564
  • [8] What are the challenges involved in the strategies for future antibody-drug conjugate discovery and development for oncology?
    Begum, Sajeli Ahil
    Kamal, Ahmed
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (06) : 591 - 596
  • [9] Antibody-drug conjugate for advanced melanoma?
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2014, 15 (12): : E534 - E534
  • [10] Sacituzumab govitecan: an antibody-drug conjugate
    Sahota, Sheena
    Vahdat, Linda T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (08) : 1027 - 1031
12345